Showing results (311-320 of 384) with videos related to

Sort By:
Pageof 39
BJU International|December 13, 2017
Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancerSasha C Druskin, Jeffrey J Tosoian, Allen Young, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 8, 2010
A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressivenessLori J Sokoll, Martin G Sanda, Ziding Feng, et al.
BJU International|June 14, 2013
Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experiencePhillip M Pierorazio, Jeffrey K Mullins, Ashley E Ross, et al.
Urology|February 25, 2003
Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysisLori J Sokoll, Daniel W Chan, Stephen D Mikolajczyk, et al.
BJU International|January 7, 2017
Prostate Health Index density improves detection of clinically significant prostate cancerJeffrey J Tosoian, Sasha C Druskin, Darian Andreas, et al.
Clinical Genitourinary Cancer|September 19, 2019
PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical ProstatectomyMark C Markowski, Yongmei Chen, Zhaoyong Feng, et al.
Cancer|June 7, 2021
COVID-19 outcomes in hospitalized patients with active cancer: Experiences from a major New York City health care systemChen Fu, James H Stoeckle, Lena Masri, et al.
The Prostate|September 16, 2004
Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarraysDennis A Faith, William B Isaacs, James D Morgan, et al.
BJU International|November 15, 2011
Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsiesBruce J Trock, Michelle J Brotzman, Leslie A Mangold, et al.
The Journal of Urology|June 16, 2009
Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomyLionel L Bañez, Leon Sun, Bruce J Trock, et al.
Pageof 39